SCOPUS 정보 검색 플랫폼

Journal of Neurology

Volumn 257, Issue 9, 2010, Pages 1590-1593

Advances in multiple sclerosis research in 2009

(2) Nessler, Stefan a Brück, Wolfgang a

a UNIVERSITY MEDICAL CENTER GÖTTINGEN (Germany)

Author keywords

Advances; Multiple sclerosis; Neuromyelitis optica

Indexed keywords

BETA INTERFERON; GLATIRAMER; HLA DR15 ANTIGEN; MITOXANTRONE; NATALIZUMAB; TERIFLUNOMIDE;

CELL MIGRATION; ENVIRONMENTAL FACTOR; FATIGUE; HAPLOTYPE; HEREDITY; HUMAN; INFLAMMATORY CELL; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA;

EID: 77957354070 PISSN: 03405354 EISSN: 14321459 Source Type: Journal
DOI: 10.1007/s00415-010-5689-y Document Type: Review

Times cited : (11)

References (22)

1
- 73449103627
- Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution
- 10.1007/s00415-009-5171-x 19479168
- E Bizzoco F Lolli AM Repice B Hakiki M Falcini A Barilaro R Taiuti G Siracusa MP Amato T Biagioli S Lori M Moretti A Vinattieri P Nencini L Massacesi S Mata 2009 Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution J Neurol 256 1891 1898 10.1007/s00415-009-5171-x 19479168
- (2009) J Neurol , vol.256 , pp. 1891-1898
- Bizzoco, E.¹ Lolli, F.² Repice, A.M.³ Hakiki, B.⁴ Falcini, M.⁵ Barilaro, A.⁶ Taiuti, R.⁷ Siracusa, G.⁸ Amato, M.P.⁹ Biagioli, T.¹⁰ Lori, S.¹¹ Moretti, M.¹² Vinattieri, A.¹³ Nencini, P.¹⁴ Massacesi, L.¹⁵ Mata, S.¹⁶

2
- 62149092563
- An epidemiological study of neuromyelitis optica in Cuba
- 10.1007/s00415-009-0009-0 19224310
- JA Cabrera-Gomez JF Kurtzke A Gonzalez-Quevedo R Lara-Rodriguez 2009 An epidemiological study of neuromyelitis optica in Cuba J Neurol 256 35 44 10.1007/s00415-009-0009-0 19224310
- (2009) J Neurol , vol.256 , pp. 35-44
- Cabrera-Gomez, J.A.¹ Kurtzke, J.F.² Gonzalez-Quevedo, A.³ Lara-Rodriguez, R.⁴

3
- 67650466999
- Intracortical excitability in patients with relapsing-remitting and secondary progressive multiple sclerosis
- 10.1007/s00415-009-5047-0 1:STN:280:DC%2BD1MvivFartA%3D%3D 19252788
- A Conte D Lenzi V Frasca F Gilio E Giacomelli M Gabriele CM Bettolo E Iacovelli P Pantano C Pozzilli M Inghilleri 2009 Intracortical excitability in patients with relapsing-remitting and secondary progressive multiple sclerosis J Neurol 256 933 938 10.1007/s00415-009-5047-0 1:STN:280:DC%2BD1MvivFartA%3D%3D 19252788
- (2009) J Neurol , vol.256 , pp. 933-938
- Conte, A.¹ Lenzi, D.² Frasca, V.³ Gilio, F.⁴ Giacomelli, E.⁵ Gabriele, M.⁶ Bettolo, C.M.⁷ Iacovelli, E.⁸ Pantano, P.⁹ Pozzilli, C.¹⁰ Inghilleri, M.¹¹

4
- 67349100990
- Candidate gene analysis of selectin cluster in patients with multiple sclerosis
- 10.1007/s00415-009-5016-7 1:CAS:528:DC%2BD1MXmtVKmsrg%3D 19240957
- C Fenoglio D Scalabrini L Piccio RM De E Venturelli F Cortini C Villa M Serpente B Parks J Rinker AH Cross N Bresolin E Scarpini D Galimberti 2009 Candidate gene analysis of selectin cluster in patients with multiple sclerosis J Neurol 256 832 833 10.1007/s00415-009-5016-7 1:CAS:528:DC%2BD1MXmtVKmsrg%3D 19240957
- (2009) J Neurol , vol.256 , pp. 832-833
- Fenoglio, C.¹ Scalabrini, D.² Piccio, L.³ De, R.M.⁴ Venturelli, E.⁵ Cortini, F.⁶ Villa, C.⁷ Serpente, M.⁸ Parks, B.⁹ Rinker, J.¹⁰ Cross, A.H.¹¹ Bresolin, N.¹² Scarpini, E.¹³ Galimberti, D.¹⁴

5
- 71949125048
- HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque country, Spain)
- 10.1007/s00415-009-5223-2 1:CAS:528:DC%2BD1MXhsVGls73L
- O Fernandez A Antiguedad MJ Pinto-Medel MM Mendibe N Acosta B Oliver M Guerrero M Papais-Alvarenga V Fernandez-Sanchez L Leyva 2009 HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque country, Spain) J Neurol 256 1977 1988 10.1007/s00415-009-5223-2 1:CAS:528:DC%2BD1MXhsVGls73L
- (2009) J Neurol , vol.256 , pp. 1977-1988
- Fernandez, O.¹ Antiguedad, A.² Pinto-Medel, M.J.³ Mendibe, M.M.⁴ Acosta, N.⁵ Oliver, B.⁶ Guerrero, M.⁷ Papais-Alvarenga, M.⁸ Fernandez-Sanchez, V.⁹ Leyva, L.¹⁰

6
- 67349166482
- Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis
- 10.1007/s00415-009-0110-4 1:CAS:528:DC%2BD1MXltlKrsrY%3D 19271108
- T Hayton J Furby KJ Smith DR Altmann R Brenner J Chataway RA Hughes K Hunter DJ Tozer DH Miller R Kapoor 2009 Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis J Neurol 256 427 435 10.1007/s00415-009-0110-4 1:CAS:528:DC%2BD1MXltlKrsrY%3D 19271108
- (2009) J Neurol , vol.256 , pp. 427-435
- Hayton, T.¹ Furby, J.² Smith, K.J.³ Altmann, D.R.⁴ Brenner, R.⁵ Chataway, J.⁶ Hughes, R.A.⁷ Hunter, K.⁸ Tozer, D.J.⁹ Miller, D.H.¹⁰ Kapoor, R.¹¹

7
- 67349250932
- The efficacy of natalizumab in patients with relapsing multiple sclerosis: Subgroup analyses of AFFIRM and SENTINEL
- 10.1007/s00415-009-0093-1 1:CAS:528:DC%2BD1MXltlKrs78%3D 19308305
- M Hutchinson L Kappos PA Calabresi C Confavreux G Giovannoni SL Galetta E Havrdova FD Lublin DH Miller PW O'Connor JT Phillips CH Polman EW Radue RA Rudick WH Stuart A Wajgt B Weinstock-Guttman DR Wynn F Lynn MA Panzara 2009 The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL J Neurol 256 405 415 10.1007/s00415-009-0093-1 1:CAS:528:DC%2BD1MXltlKrs78%3D 19308305
- (2009) J Neurol , vol.256 , pp. 405-415
- Hutchinson, M.¹ Kappos, L.² Calabresi, P.A.³ Confavreux, C.⁴ Giovannoni, G.⁵ Galetta, S.L.⁶ Havrdova, E.⁷ Lublin, F.D.⁸ Miller, D.H.⁹ O'Connor, P.W.¹⁰ Phillips, J.T.¹¹ Polman, C.H.¹² Radue, E.W.¹³ Rudick, R.A.¹⁴ Stuart, W.H.¹⁵ Wajgt, A.¹⁶ Weinstock-Guttman, B.¹⁷ Wynn, D.R.¹⁸ Lynn, F.¹⁹ Panzara, M.A.²⁰ more..

8
- 67650466970
- MRI criteria in MS patients with negative and positive oligoclonal bands: Equal fulfillment of Barkhof's criteria but different lesion patterns
- 10.1007/s00415-009-5081-y 19252765
- HB Huttner PD Schellinger T Struffert G Richter T Engelhorn T Bassemir M Maurer M Garcia S Schwab M Kohrmann A Doerfler 2009 MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof's criteria but different lesion patterns J Neurol 256 1121 1125 10.1007/s00415-009-5081-y 19252765
- (2009) J Neurol , vol.256 , pp. 1121-1125
- Huttner, H.B.¹ Schellinger, P.D.² Struffert, T.³ Richter, G.⁴ Engelhorn, T.⁵ Bassemir, T.⁶ Maurer, M.⁷ Garcia, M.⁸ Schwab, S.⁹ Kohrmann, M.¹⁰ Doerfler, A.¹¹

9
- 65749119370
- Multiple sclerosis patients' benefit-risk preferences: Serious adverse event risks versus treatment efficacy
- 10.1007/s00415-009-0084-2 19444531
- FR Johnson HG Van S Ozdemir S Hass J White G Francis DW Miller JT Phillips 2009 Multiple sclerosis patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy J Neurol 256 554 562 10.1007/s00415-009-0084-2 19444531
- (2009) J Neurol , vol.256 , pp. 554-562
- Johnson, F.R.¹ Van, H.G.² Ozdemir, S.³ Hass, S.⁴ White, J.⁵ Francis, G.⁶ Miller, D.W.⁷ Phillips, J.T.⁸

10
- 67349149115
- Modafinil effects in multiple sclerosis patients with fatigue
- 10.1007/s00415-009-0152-7 1:CAS:528:DC%2BD1MXlvVyqu78%3D 19367356
- R Lange M Volkmer C Heesen J Liepert 2009 Modafinil effects in multiple sclerosis patients with fatigue J Neurol 256 645 650 10.1007/s00415-009-0152-7 1:CAS:528:DC%2BD1MXlvVyqu78%3D 19367356
- (2009) J Neurol , vol.256 , pp. 645-650
- Lange, R.¹ Volkmer, M.² Heesen, C.³ Liepert, J.⁴

11
- 70349652279
- Serum uric acid and risk of multiple sclerosis
- 10.1007/s00415-009-5170-y 1:CAS:528:DC%2BD1MXht1SktL3K 19468784
- J Massa E O'Reilly KL Munger GN Delorenze A Ascherio 2009 Serum uric acid and risk of multiple sclerosis J Neurol 256 1643 1648 10.1007/s00415-009-5170-y 1:CAS:528:DC%2BD1MXht1SktL3K 19468784
- (2009) J Neurol , vol.256 , pp. 1643-1648
- Massa, J.¹ O'Reilly, E.² Munger, K.L.³ Delorenze, G.N.⁴ Ascherio, A.⁵

12
- 62149096116
- Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis
- 10.1007/s00415-009-0075-3 1:CAS:528:DC%2BD1MXisl2qsro%3D 19169851
- JE Merrill S Hanak SF Pu J Liang C Dang D Iglesias-Bregna B Harvey B Zhu K McMonagle-Strucko 2009 Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis J Neurol 256 89 103 10.1007/s00415-009-0075-3 1:CAS:528:DC%2BD1MXisl2qsro%3D 19169851
- (2009) J Neurol , vol.256 , pp. 89-103
- Merrill, J.E.¹ Hanak, S.² Pu, S.F.³ Liang, J.⁴ Dang, C.⁵ Iglesias-Bregna, D.⁶ Harvey, B.⁷ Zhu, B.⁸ McMonagle-Strucko, K.⁹

13
- 71849106873
- Factors that influence the employment status of people with multiple sclerosis: A multi-national study
- 10.1007/s00415-009-5225-0
- UM Messmer C Specchia MA Battaglia DM Miller 2009 Factors that influence the employment status of people with multiple sclerosis: a multi-national study J Neurol 256 1989 1996 10.1007/s00415-009-5225-0
- (2009) J Neurol , vol.256 , pp. 1989-1996
- Messmer, U.M.¹ Specchia, C.² Battaglia, M.A.³ Miller, D.M.⁴

14
- 67650458525
- The effects of l-amphetamine sulfate on cognition in MS patients: Results of a randomized controlled trial
- 10.1007/s00415-009-5074-x 1:CAS:528:DC%2BD1MXotlehtL4%3D 19263186
- SA Morrow T Kaushik P Zarevics D Erlanger MF Bear FE Munschauer RH Benedict 2009 The effects of l-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial J Neurol 256 1095 1102 10.1007/s00415-009-5074-x 1:CAS:528:DC%2BD1MXotlehtL4%3D 19263186
- (2009) J Neurol , vol.256 , pp. 1095-1102
- Morrow, S.A.¹ Kaushik, T.² Zarevics, P.³ Erlanger, D.⁴ Bear, M.F.⁵ Munschauer, F.E.⁶ Benedict, R.H.⁷

15
- 67650459142
- Clinical predictors of early second event in patients with clinically isolated syndrome
- 10.1007/s00415-009-5063-0 19252775
- EM Mowry M Pesic B Grimes SR Deen P Bacchetti E Waubant 2009 Clinical predictors of early second event in patients with clinically isolated syndrome J Neurol 256 1061 1066 10.1007/s00415-009-5063-0 19252775
- (2009) J Neurol , vol.256 , pp. 1061-1066
- Mowry, E.M.¹ Pesic, M.² Grimes, B.³ Deen, S.R.⁴ Bacchetti, P.⁵ Waubant, E.⁶

16
- 69549114460
- Clinical implications of a possible role of vitamin D in multiple sclerosis
- 10.1007/s00415-009-5139-x 1:CAS:528:DC%2BD1MXhtVCgurbJ 19399382
- C Pierrot-Deseilligny 2009 Clinical implications of a possible role of vitamin D in multiple sclerosis J Neurol 256 1468 1479 10.1007/s00415-009-5139-x 1:CAS:528:DC%2BD1MXhtVCgurbJ 19399382
- (2009) J Neurol , vol.256 , pp. 1468-1479
- Pierrot-Deseilligny, C.¹

17
- 67349263039
- Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis
- Pittas F, Ponsonby AL, van der Mei IA, Taylor BV, Blizzard L, Groom P, Ukoumunne OC, Dwyer T (2009) Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis. J Neurol 256:577-585
- (2009) J Neurol , vol.256 , pp. 577-585
- Pittas, F.¹ Ponsonby, A.L.² Van Der Mei, I.A.³ Taylor, B.V.⁴ Blizzard, L.⁵ Groom, P.⁶ Ukoumunne, O.C.⁷ Dwyer, T.⁸

18
- 73449089131
- Symptomatology of MS: Results from the German MS Registry
- 10.1007/s00415-009-5257-5 19629565
- K Stuke P Flachenecker UK Zettl WG Elias M Freidel J Haas D Pitschnau-Michel S Schimrigk P Rieckmann 2009 Symptomatology of MS: results from the German MS Registry J Neurol 256 1932 1935 10.1007/s00415-009-5257-5 19629565
- (2009) J Neurol , vol.256 , pp. 1932-1935
- Stuke, K.¹ Flachenecker, P.² Zettl, U.K.³ Elias, W.G.⁴ Freidel, M.⁵ Haas, J.⁶ Pitschnau-Michel, D.⁷ Schimrigk, S.⁸ Rieckmann, P.⁹

19
- 65749088247
- Factors that influence adherence with disease-modifying therapy in MS
- 10.1007/s00415-009-0096-y 19444532
- K Treadaway G Cutter A Salter S Lynch J Simsarian J Corboy D Jeffery B Cohen K Mankowski J Guarnaccia L Schaeffer R Kanter D Brandes C Kaufman D Duncan E Marder A Allen J Harney J Cooper D Woo O Stuve M Racke EM Frohman 2009 Factors that influence adherence with disease-modifying therapy in MS J Neurol 256 568 576 10.1007/s00415-009-0096-y 19444532
- (2009) J Neurol , vol.256 , pp. 568-576
- Treadaway, K.¹ Cutter, G.² Salter, A.³ Lynch, S.⁴ Simsarian, J.⁵ Corboy, J.⁶ Jeffery, D.⁷ Cohen, B.⁸ Mankowski, K.⁹ Guarnaccia, J.¹⁰ Schaeffer, L.¹¹ Kanter, R.¹² Brandes, D.¹³ Kaufman, C.¹⁴ Duncan, D.¹⁵ Marder, E.¹⁶ Allen, A.¹⁷ Harney, J.¹⁸ Cooper, J.¹⁹ Woo, D.²⁰ more..

20
- 67349277156
- Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities
- 10.1007/s00415-009-0039-7 19308306
- H Tremlett Y Zhao V Devonshire 2009 Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities J Neurol 256 374 381 10.1007/s00415-009-0039-7 19308306
- (2009) J Neurol , vol.256 , pp. 374-381
- Tremlett, H.¹ Zhao, Y.² Devonshire, V.³

21
- 71849113120
- Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis
- 10.1007/s00415-009-5274-4 1:CAS:528:DC%2BD1MXhsVGls7rM
- A Uzawa M Mori M Ito T Uchida S Hayakawa S Masuda S Kuwabara 2009 Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis J Neurol 256 2082 2084 10.1007/s00415-009-5274-4 1:CAS:528:DC%2BD1MXhsVGls7rM
- (2009) J Neurol , vol.256 , pp. 2082-2084
- Uzawa, A.¹ Mori, M.² Ito, M.³ Uchida, T.⁴ Hayakawa, S.⁵ Masuda, S.⁶ Kuwabara, S.⁷

22
- 69549120011
- Migration and multiple sclerosis in Alaskan military veterans
- 10.1007/s00415-009-5123-5 19377862
- MT Wallin WF Page JF Kurtzke 2009 Migration and multiple sclerosis in Alaskan military veterans J Neurol 256 1413 1417 10.1007/s00415-009-5123-5 19377862
- (2009) J Neurol , vol.256 , pp. 1413-1417
- Wallin, M.T.¹ Page, W.F.² Kurtzke, J.F.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.